TOVXNYSEPharmaceutical PreparationsFiscal year ends December 31
Theriva Biologics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$0.20−0.00 (-1.54%)
Close on Oct 19, 2026
- Market cap
- $9.39M
- P/E (TTM)
- –
- Dividend yield
- –
Theriva Biologics statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Market Cap | $9.39M | $166.30M |
| Enterprise Value | -$1.94M | $88.19M |
Income (trailing twelve months)
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Operating Income | -$24.05M | -$21.40M |
| Pretax Income | -$23.74M | -$14.11M |
| EBITDA | -$23.94M | -$17.37M |
| EPS (Diluted) | -$2.08 | -$0.83 |
Returns
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -105.7% | -37.6% |
Balance sheet
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $11.34M | $61.43M |
| Net Cash (Debt) | $11.34M | $15.44M |
| Net Cash Per Share | $0.25 | $0.66 |
| Working Capital | $1.56M | $75.09M |
Financial position
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Current Ratio | 1.13 | 3.32 |
| Quick Ratio | 0.94 | 2.39 |
| Interest Coverage | -394.28 | -7.11 |
Cash flow (trailing twelve months)
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.67M | -$12.35M |
| Capital Expenditures | -$35.00K | -$1.08M |
| Free Cash Flow | -$16.70M | -$20.16M |
| FCF Per Share | -$0.36 | -$0.42 |
Efficiency
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Employee Count | 16 | 74 |
Dividends and yields
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| FCF Yield | -177.8% | -8.79% |
Shares
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Shares Outstanding | 45,892,700 | 58,127,000 |
| Shares Change (YoY) | 800.6% | 10.9% |
| Shares Change (QoQ) | 0.00% | 0.54% |
| Float | 45,403,100 | 48,980,900 |
| Shares Held by Insiders | 1.07% | 11.6% |
| Shares Held by Institutions | 4.32% | 59.4% |
Scores
| Measure | Theriva Biologics | Industry median |
|---|---|---|
| Altman Z-Score | -16.59 | -0.27 |
Calculated by StockData from Theriva Biologics's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.